Profile: Globus Medical Inc (GMED.N)
16.75USD
1 Aug 2013
$-0.01 (-0.06%)
$16.76
$16.82
$16.88
$16.55
78,570
137,319
$19.90
$10.26
Globus Medical, Inc. (Globus), incorporated on March 3, 2003, is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. As of December 31, 2011, the Company had launched over 110 products and offers a portfolio of products addressing a range of spinal pathologies, anatomies and surgical approaches. The Company's products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company's Innovative Fusion products address a range of spinal fusion surgical procedures. Spinal fusion is a surgical procedure to correct problems with the individual vertebrae, the interlocking bones making up the spine, by preventing movement of the affected bones. In July 2012, the Company acquired the assets of a small company with operations in the United States and Germany, including a new product designed to treat vertebral compression fractures (VCFs).
Innovative Fusion
The Company's products focus the entire spine with Innovative Fusion products for use in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. The Company's REVERE pedicle screw and rod system incorporates a convenient non-threaded locking cap design that eases building of thoracolumbar fixation constructs to readily adapt to the patient's anatomy and condition, for a range of clinical applications. Certain other of the Company's products, such as its XPAND and FORTIFY corpectomy devices that incorporate smooth expansion capability, have a range of size options for optimal fit, and are manufactured from radiolucent polyetheretherketone (PEEK) to allow for postoperative radiographic visualization. Certain of the Company's other products, such as its COALITION and INDEPENDENCE stand-alone interbody fusion devices, simplify the surgical technique by reducing steps and hardware while providing confident stabilization. The depth of the Company's Innovative Fusion portfolio encompasses treatment modalities from the occiput to the sacrum, with designs and features that provide key improvements to the standards of care.
Disruptive Technologies
The Company has a product portfolio and pipelines of Disruptive Technologies, including MIS, motion preservation, and advanced biomaterials technologies, as well as interventional pain management solutions, including treatments for VCFs. The Company's MIS products enable a surgeon to perform a procedure less invasively to minimize tissue disruption and maximize native anatomy, which may lead to better patient recovery and fewer approach-related complications. The Company's MARS 3V retractor system facilitates smaller incisions with the use of positionable radiolucent retractor blades to access the surgical site and to allow both direct and radiographic visualization. The Company's CALIBER , RISE and SIGNATURE interbody spacers are designed for reliable delivery through smaller MIS incisions with streamlined implants and instruments.
The Company's REVOLVE pedicle screw system is designed for MIS screw and rod insertion through small incisions, and utilizes a convenient non-threaded locking cap design. Other Disruptive Technology products, such as TRANSITION, provide for stabilization that is less rigid than traditional pedicle screw systems for more natural load distribution to help promote fusion while maintaining stability. Similarly, the Company's motion preservation products, such as SECURE-C and SECURE-CR, are arthroplasty devices that allow segmental motion, are semi-constrained to enhance stability, and provide alternatives to fusion in the treatment of degenerative conditions. The Company's advanced biomaterials products, including MICROFUSE resorbable bone void filler and CONDUCT ceramic-collagen, are well suited for posterolateral fusion procedures in which the Company's stabilization systems are also used. The Company's AFFIRM product allows for the treatment of painful VCFs earlier in the continuum of care.
The Company competes with Medtronic, the DePuy Synthes Companies, Stryker, NuVasive, Alphatec Spine, Orthofix International, and Zimmer.
Company Address
Globus Medical Inc
Valley Forge Business Center
2560 General Armistead Avenue
AUDUBON PA 19403
P: +1610.9301800
F: +1610.9302042
Company Web Links
| Name | Compensation |
|---|---|
David Paul |
1,133,100 |
David Demski |
897,375 |
Richard Baron |
1,176,020 |
A. Brett Murphy |
695,770 |
David Davidar |
-- |

